{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:45:08Z","timestamp":1792640708959,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00125-017-4269-4","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T07:50:10Z","timestamp":1492847410000},"page":"1163-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":193,"title":["Diabetes, bone and glucose-lowering agents: basic biology"],"prefix":"10.1007","volume":"60","author":[{"given":"Beata","family":"Lecka-Czernik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","unstructured":"Schwartz AV (2017) Diabetes, bone and glucose-lowering agents: clinical outcomes. Diabetologia. doi: \n10.1007\/s00125-017-4283-6","DOI":"10.1007\/s00125-017-4283-6"},{"key":"4269_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00223-016-0175-x","volume":"100","author":"J Starup-Linde","year":"2017","unstructured":"Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B (2017) Epidemiology of fractures in diabetes. Calcif Tissue Int 100:109\u2013121","journal-title":"Calcif Tissue Int"},{"key":"4269_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","volume":"29","author":"JN Farr","year":"2014","unstructured":"Farr JN, Drake MT, Amin S, Melton LJ 3rd, McCready LK, Khosla S (2014) In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 29:787\u2013795","journal-title":"J Bone Miner Res"},{"key":"4269_CR4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jbmr.2574","volume":"30","author":"B Lecka-Czernik","year":"2015","unstructured":"Lecka-Czernik B, Rosen CJ (2015) Energy excess, glucose utilization, and skeletal remodeling: new insights. J Bone Miner Res 30:1356\u20131361","journal-title":"J Bone Miner Res"},{"key":"4269_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diab.44.7.775","volume":"44","author":"JC Krakauer","year":"1995","unstructured":"Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44:775\u2013782","journal-title":"Diabetes"},{"key":"4269_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11914-015-0265-0","volume":"13","author":"MR Rubin","year":"2015","unstructured":"Rubin MR (2015) Bone cells and bone turnover in diabetes mellitus. Curr Osteoporos Rep 13:186\u2013191","journal-title":"Curr Osteoporos Rep"},{"key":"4269_CR7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","volume":"28","author":"JM Patsch","year":"2013","unstructured":"Patsch JM, Burghardt AJ, Yap SP et al (2013) Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 28:313\u2013324","journal-title":"J Bone Miner Res"},{"key":"4269_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3057","author":"AG Nilsson","year":"2016","unstructured":"Nilsson AG, Sundh D, Johansson L et al (2016) Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material strength and poorer physical function in elderly women: a population-based study. J Bone Miner Res. doi:\n10.1002\/jbmr.3057","journal-title":"J Bone Miner Res"},{"key":"4269_CR9","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cell.2015.05.029","volume":"161","author":"J Wei","year":"2015","unstructured":"Wei J, Shimazu J, Makinistoglu MP et al (2015) Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell 161:1576\u20131591","journal-title":"Cell"},{"key":"4269_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","volume":"26","author":"TL Clemens","year":"2011","unstructured":"Clemens TL, Karsenty G (2011) The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 26:677\u2013680","journal-title":"J Bone Miner Res"},{"key":"4269_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T et al (2010) Insulin signalling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296\u2013308","journal-title":"Cell"},{"key":"4269_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2015.05.021","volume":"22","author":"NG Kondegowda","year":"2015","unstructured":"Kondegowda NG, Fenutria R, Pollack IR et al (2015) Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-kappaB ligand pathway. Cell Metab 22:77\u201385","journal-title":"Cell Metab"},{"key":"4269_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","volume":"142","author":"K Fulzele","year":"2010","unstructured":"Fulzele K, Riddle RC, Digirolamo DJ et al (2010) Insulin receptor signalling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142:309\u2013319","journal-title":"Cell"},{"key":"4269_CR14","first-page":"1","volume":"124","author":"J Wei","year":"2014","unstructured":"Wei J, Ferron M, Clarke CJ et al (2014) Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest 124:1\u201313","journal-title":"J Clin Invest"},{"key":"4269_CR15","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jcp.24954","volume":"230","author":"CR Doucette","year":"2015","unstructured":"Doucette CR, Horowitz MC, Berry R et al (2015) A high fat diet increases bone marrow adipose tissue (MAT) but does not alter trabecular or cortical bone mass in C57BL\/6J mice. J Cell Physiol 230:2032\u20132037","journal-title":"J Cell Physiol"},{"key":"4269_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2015.01.001","volume":"410","author":"B Lecka-Czernik","year":"2015","unstructured":"Lecka-Czernik B, Stechschulte LA, Czernik PJ, Dowling AR (2015) High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Mol Cell Endocrinol 410:35\u201341","journal-title":"Mol Cell Endocrinol"},{"key":"4269_CR17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebiom.2016.06.040","volume":"10","author":"LA Stechschulte","year":"2016","unstructured":"Stechschulte LA, Czernik PJ, Rotter ZC et al (2016) PPARG post-translational modifications regulate bone formation and bone resorption. EBioMedicine 10:174\u2013184","journal-title":"EBioMedicine"},{"key":"4269_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11914-010-0016-1","volume":"8","author":"B Lecka-Czernik","year":"2010","unstructured":"Lecka-Czernik B (2010) PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism. Curr Osteoporos Rep 8:84\u201390","journal-title":"Curr Osteoporos Rep"},{"key":"4269_CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jcp.25102","volume":"231","author":"C Ge","year":"2016","unstructured":"Ge C, Cawthorn WP, Li Y, Zhao G, MacDougald OA, Franceschi RT (2016) Reciprocal control of osteogenic and adipogenic differentiation by ERK\/MAP kinase phosphorylation of Runx2 and PPARgamma transcription factors. J Cell Physiol 231:587\u2013596","journal-title":"J Cell Physiol"},{"key":"4269_CR20","doi-asserted-by":"crossref","first-page":"24475","DOI":"10.1074\/jbc.M116.752493","volume":"291","author":"LA Stechschulte","year":"2016","unstructured":"Stechschulte LA, Ge C, Hinds TD Jr, Sanchez ER, Franceschi RT, Lecka-Czernik B (2016) Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARgamma (peroxisome proliferator-activated receptor gamma) and RUNX2 (runt-related transcription factor 2). J Biol Chem 291:24475\u201324486","journal-title":"J Biol Chem"},{"key":"4269_CR21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cmet.2010.04.015","volume":"11","author":"W Wei","year":"2010","unstructured":"Wei W, Wang X, Yang M, Smith LC, Dechow PC, Wan Y (2010) PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11:503\u2013516","journal-title":"Cell Metab"},{"key":"4269_CR22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1210\/en.2006-1587","volume":"148","author":"OP Lazarenko","year":"2007","unstructured":"Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B (2007) Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 148:2669\u20132680","journal-title":"Endocrinology"},{"key":"4269_CR23","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/db14-1642","volume":"64","author":"BM Abdallah","year":"2015","unstructured":"Abdallah BM, Ditzel N, Laborda J, Karsenty G, Kassem M (2015) DLK1 regulates whole-body glucose metabolism: a negative feedback regulation of the osteocalcin-insulin loop. Diabetes 64:3069\u20133080","journal-title":"Diabetes"},{"key":"4269_CR24","doi-asserted-by":"crossref","first-page":"eaag2809","DOI":"10.1126\/scitranslmed.aag2809","volume":"9","author":"R Tevlin","year":"2017","unstructured":"Tevlin R, Seo EY, Marecic O et al (2017) Pharmacological rescue of diabetic skeletal stem cell niches. Sci Transl Med 9:eaag2809","journal-title":"Sci Transl Med"},{"key":"4269_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-016-0149-z","volume":"99","author":"A Creecy","year":"2016","unstructured":"Creecy A, Uppuganti S, Merkel AR et al (2016) Changes in the fracture resistance of bone with the progression of type 2 diabetes in the ZDSD rat. Calcif Tissue Int 99:289\u2013301","journal-title":"Calcif Tissue Int"},{"key":"4269_CR26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1089\/scd.2016.0067","volume":"25","author":"E Aikawa","year":"2016","unstructured":"Aikawa E, Fujita R, Asai M, Kaneda Y, Tamai K (2016) Receptor for advanced glycation end products-mediated signalling impairs the maintenance of bone marrow mesenchymal stromal cells in diabetic model mice. Stem Cells Dev 25:1721\u20131732","journal-title":"Stem Cells Dev"},{"key":"4269_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2005.12.107","volume":"340","author":"KH Ding","year":"2006","unstructured":"Ding KH, Wang ZZ, Hamrick MW et al (2006) Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340:1091\u20131097","journal-title":"Biochem Biophys Res Commun"},{"key":"4269_CR28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","volume":"94","author":"AV Schwartz","year":"2009","unstructured":"Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94:2380\u20132386","journal-title":"J Clin Endocrinol Metab"},{"key":"4269_CR29","first-page":"662","volume":"4","author":"MH Lafage-Proust","year":"2015","unstructured":"Lafage-Proust MH, Roche B, Langer M et al (2015) Assessment of bone vascularization and its role in bone remodeling. Bonekey Rep 4:662","journal-title":"Bonekey Rep"},{"key":"4269_CR30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2337\/dc15-0783","volume":"38","author":"DR Weber","year":"2015","unstructured":"Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38:1913\u20131920","journal-title":"Diabetes Care"},{"key":"4269_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","volume":"174","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Hansen S, Frost M et al (2016) Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. Eur J Endocrinol 174:115\u2013124","journal-title":"Eur J Endocrinol"},{"key":"4269_CR32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","volume":"46","author":"T Tanikawa","year":"2009","unstructured":"Tanikawa T, Okada Y, Tanikawa R, Tanaka Y (2009) Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK. J Vasc Res 46:572\u2013580","journal-title":"J Vasc Res"},{"key":"4269_CR33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cbf.3164","volume":"34","author":"S Gohin","year":"2016","unstructured":"Gohin S, Carriero A, Chenu C, Pitsillides AA, Arnett TR, Marenzana M (2016) The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB\/c mice. Cell Biochem Funct 34:52\u201362","journal-title":"Cell Biochem Funct"},{"key":"4269_CR34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00125-014-3224-x","volume":"57","author":"K Eckardt","year":"2014","unstructured":"Eckardt K, Gorgens SW, Raschke S, Eckel J (2014) Myokines in insulin resistance and type 2 diabetes. Diabetologia 57:1087\u20131099","journal-title":"Diabetologia"},{"key":"4269_CR35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bone.2007.07.022","volume":"41","author":"X Yang","year":"2007","unstructured":"Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41:928\u2013936","journal-title":"Bone"},{"key":"4269_CR36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2016.05.004","volume":"23","author":"P Mera","year":"2016","unstructured":"Mera P, Laue K, Ferron M et al (2016) Osteocalcin signalling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 23:1078\u20131092","journal-title":"Cell Metab"},{"key":"4269_CR37","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1073\/pnas.1516622112","volume":"112","author":"G Colaianni","year":"2015","unstructured":"Colaianni G, Cuscito C, Mongelli T et al (2015) The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A 112:12157\u201312162","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4269_CR38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/dc13-2289","volume":"37","author":"C Hampp","year":"2014","unstructured":"Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK (2014) Use of antidiabetic drugs in the U.S., 2003\u20132012. Diabetes Care 37:1367\u20131374","journal-title":"Diabetes Care"},{"key":"4269_CR39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bone.2010.12.003","volume":"48","author":"WG Jang","year":"2011","unstructured":"Jang WG, Kim EJ, Bae IH et al (2011) Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone 48:885\u2013893","journal-title":"Bone"},{"key":"4269_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2016.11.011","volume":"440","author":"SC Chen","year":"2017","unstructured":"Chen SC, Brooks R, Houskeeper J et al (2017) Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms. Mol Cell Endocrinol 440:57\u201368","journal-title":"Mol Cell Endocrinol"},{"key":"4269_CR41","first-page":"4847812","volume":"2016","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang Y, Jin X et al (2016) Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE\/NFkappaB pathway suppression. J Diabetes Res 2016:4847812","journal-title":"J Diabetes Res"},{"key":"4269_CR42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-016-0408-3","volume":"15","author":"JW Yu","year":"2016","unstructured":"Yu JW, Deng YP, Han X, Ren GF, Cai J, Jiang GJ (2016) Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice. Cardiovasc Diabetol 15:88","journal-title":"Cardiovasc Diabetol"},{"key":"4269_CR43","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","volume":"112","author":"QG Mai","year":"2011","unstructured":"Mai QG, Zhang ZM, Xu S et al (2011) Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem 112:2902\u20132909","journal-title":"J Cell Biochem"},{"key":"4269_CR44","doi-asserted-by":"crossref","first-page":"e112243","DOI":"10.1371\/journal.pone.0112243","volume":"9","author":"P Ma","year":"2014","unstructured":"Ma P, Gu B, Xiong W et al (2014) Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K\/Akt\/eNOS pathway in a high glucose microenvironment. PLoS One 9:e112243","journal-title":"PLoS One"},{"key":"4269_CR45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pharep.2013.12.013","volume":"66","author":"J Fronczek-Sokol","year":"2014","unstructured":"Fronczek-Sokol J, Pytlik M (2014) Effect of glimepiride on the skeletal system of ovariectomized and non-ovariectomized rats. Pharmacol Rep 66:412\u2013417","journal-title":"Pharmacol Rep"},{"key":"4269_CR46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","volume":"81","author":"M Pereira","year":"2015","unstructured":"Pereira M, Jeyabalan J, Jorgensen CS et al (2015) Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. Bone 81:459\u2013467","journal-title":"Bone"},{"key":"4269_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.07.025","volume":"82","author":"KM Thrailkill","year":"2016","unstructured":"Thrailkill KM, Nyman JS, Bunn RC et al (2016) The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes. Bone 82:101\u2013107","journal-title":"Bone"},{"key":"4269_CR48","doi-asserted-by":"crossref","unstructured":"Lecka-Czernik B (2010) Bone loss in diabetes: use of anti-diabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporosis Rep 8:178\u2013184","DOI":"10.1007\/s11914-010-0027-y"},{"key":"4269_CR49","doi-asserted-by":"crossref","first-page":"23517","DOI":"10.1074\/jbc.M111.324814","volume":"287","author":"A Mieczkowska","year":"2012","unstructured":"Mieczkowska A, Basle MF, Chappard D, Mabilleau G (2012) Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism. J Biol Chem 287:23517\u201323526","journal-title":"J Biol Chem"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4269-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T08:32:02Z","timestamp":1496219522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4269-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4269-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,22]]}}}